Erica L Cantor

5PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersCancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 01, 2025
Fidelity of Next-Generation Sequencing to Predict Human Epidermal Growth Factor 2 Overexpression Across Solid Tumors.

Mya Tran, Christopher A Fausel, Steven Bray

|May 01, 2023
Cytochrome P450 Oxidoreductase (POR) Associated with Severe Paclitaxel-Induced Peripheral Neuropathy in Patients of European Ancestry from ECOG-ACRIN E5103.

Fei Shen, Guanglong Jiang, Santosh Philips

|Jan 05, 2022
The impact of SBF2 on taxane-induced peripheral neuropathy.

Geneva M Cunningham, Fei Shen, Xi Wu

|Dec 15, 2021
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer.

Bryan P Schneider, Guanglong Jiang, Tarah J Ballinger

Pageof 1